Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-12-08

Clinical Trial Update: APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing APC-111 administered once daily for 7 days to penicillin four times daily for 10 days in patients with strep throat has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APC-111

Snippet

Sponsor: Advancis Pharmaceutical Corporation | Conditions: Pharyngitis, Tonsillitis | Phase 3 | Status: COMPLETED